证券代码 | DRIOW.O |
证券名称 | DarioHealth Corp Wt |
证券类型 | 美国权证 |
上市场所 | 纳斯达克交易所 |
上市板块 | - |
发行方式 | - |
首发上市日 | 2016-03-04 |
首发价格(元) | - |
首发数量(股) | 0 |
首发募资额(元) | - |
首发主承销商 | - |
货币单位 | - |
公司名称 | DarioHealth Corp. |
注册地址 | 美国特拉华州 |
办公地址 | 8 HaToKhen Street, Caesarea North Industrial Park, Israel |
成立日期 | 2011-08-11 |
董事会主席 | - |
公司属地 | United States 美国 |
公司网址 | www.mydario.com |
电话 | +972 (4) 770-4055 |
传真 | - |
公司简介 | DarioHealth Corp. is a leading global digital health company serving tens of thousands of users with dynamic mobile health solutions. They believe people deserve the best tools to manage their treatment, and harnessing big data, they have developed a unique way for their users to analyze and personalize their diabetes management. With their smart diabetes solution, users have direct access to track and monitor all facets of diabetes, without having the disease slow them down. The acclaimed Dario Blood Glucose Monitoring System all-in-one blood glucose meter and native smartphone app gives users an unrivaled method for self-diabetes management. DarioHealth is headquartered in Caesarea, Israel with a regional office in Burlington, Massachusetts. |